Actualités Shengtai Pharmaceutical Inc (GM) - SGTI | Actions OTCMarkets

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Annual Report of Proxy Voting Record for Management Investment Companies (n-px)

Small-Cap Value Fund 07/01/2012 to...

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FO...

Shengtai Pharmaceutical, Inc. Chairman Withdraws Preliminary Offer to Take Company Private and Dissolves Special Committee

Shengtai Pharmaceutical, Inc. Chairman Withdraws Preliminary Offer to Take Company Private and Dissolves Special Committee PR Newswire WEIFANG...

Mutual Fund Summary Prospectus (497k)

NORTHERN FUNDS Short-Intermediate Tax-Exempt Fund...

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Mutual Fund Summary Prospectus (497k)

NORTHERN FUNDS California Tax-Exempt Fund S...

Designate a New Effective Date for a Post-effective Amendment Previously Filed Pursuant to Rule 485(a) (485bxt)

As filed with the Securities and Exchange Commission on July 30, 2013 1933 Act Registration...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT...

Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results

Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results PR Newswire WEIFANG, SHANDONG, China, May. 15, 2013...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC...

Amended Statement of Beneficial Ownership (sc 13d/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washingto...

Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal Year 2013 Financial Results

Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal Year 2013 Financial Results PR Newswire WEIFANG, SHANDONG, China, Feb. 14, 2013...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Shengtai Pharmaceutical Inc (GM) (SGTI)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

SGTI Actualités

Annual Report of Proxy Voting Record for Management Investment Companies (n-px)

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

Shengtai Pharmaceutical, Inc. Chairman Withdraws Preliminary Offer to Take Company Private and Dissolves Special Committee

Mutual Fund Summary Prospectus (497k)

Amended Statement of Beneficial Ownership (sc 13d/a)

Mutual Fund Summary Prospectus (497k)

Designate a New Effective Date for a Post-effective Amendment Previously Filed Pursuant to Rule 485(a) (485bxt)

Current Report Filing (8-k)

Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results

Quarterly Report (10-q)

Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)

Amended Statement of Beneficial Ownership (sc 13d/a)

Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal Year 2013 Financial Results

Quarterly Report (10-q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Shengtai Pharmaceutical Inc (GM) (SGTI) Actualités

Shengtai Pharmaceutical Inc (GM) (SGTI)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

SGTI Actualités

Annual Report of Proxy Voting Record for Management Investment Companies (n-px)

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

Shengtai Pharmaceutical, Inc. Chairman Withdraws Preliminary Offer to Take Company Private and Dissolves Special Committee

Mutual Fund Summary Prospectus (497k)

Amended Statement of Beneficial Ownership (sc 13d/a)

Mutual Fund Summary Prospectus (497k)

Designate a New Effective Date for a Post-effective Amendment Previously Filed Pursuant to Rule 485(a) (485bxt)

Current Report Filing (8-k)

Shengtai Pharmaceutical, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results

Quarterly Report (10-q)

Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)

Amended Statement of Beneficial Ownership (sc 13d/a)

Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal Year 2013 Financial Results

Quarterly Report (10-q)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités